Medoro, A.; Davinelli, S.; Fogacci, F.; Alfieri, S.; Tiso, D.; Cicero, A.F.G.; Scapagnini, G.
Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives. Nutrients 2024, 16, 4313.
https://doi.org/10.3390/nu16244313
AMA Style
Medoro A, Davinelli S, Fogacci F, Alfieri S, Tiso D, Cicero AFG, Scapagnini G.
Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives. Nutrients. 2024; 16(24):4313.
https://doi.org/10.3390/nu16244313
Chicago/Turabian Style
Medoro, Alessandro, Sergio Davinelli, Federica Fogacci, Stefania Alfieri, Domenico Tiso, Arrigo F. G. Cicero, and Giovanni Scapagnini.
2024. "Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives" Nutrients 16, no. 24: 4313.
https://doi.org/10.3390/nu16244313
APA Style
Medoro, A., Davinelli, S., Fogacci, F., Alfieri, S., Tiso, D., Cicero, A. F. G., & Scapagnini, G.
(2024). Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives. Nutrients, 16(24), 4313.
https://doi.org/10.3390/nu16244313
